Inhibitec Overview
- Year Founded
-
2019
- Status
-
Private
- Employees
-
9
- Latest Deal Type
-
Accelerator/Inc
Inhibitec General Information
Description
Developer of monoclonal antibody therapeutics designed for the treatment of autoimmune and inflammatory diseases. The company targets a specific regulatory protein to modulate immune responses through dual-action mechanisms that suppress pro-inflammatory cells while enhancing regulatory cell activity, enabling healthcare providers to access a differentiated approach that may offer improved efficacy and broader patient applicability compared to conventional single-target treatments.
Contact Information
Website
www.inhibitec.comCorporate Office
- Calle Albert Einstein, 22
- 39011 Santander
- Spain
Corporate Office
- Calle Albert Einstein, 22
- 39011 Santander
- Spain
Inhibitec Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Accelerator/Incubator | 01-Jan-2019 | Completed | Generating Revenue |
Inhibitec Signals
Inhibitec FAQs
-
When was Inhibitec founded?
Inhibitec was founded in 2019.
-
Where is Inhibitec headquartered?
Inhibitec is headquartered in Santander, Spain.
-
What is the size of Inhibitec?
Inhibitec has 9 total employees.
-
What industry is Inhibitec in?
Inhibitec’s primary industry is Biotechnology.
-
Is Inhibitec a private or public company?
Inhibitec is a Private company.
-
What is Inhibitec’s current revenue?
The current revenue for Inhibitec is .
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process